chr19-53237562-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182609.4(ZNF677):āc.1165A>Gā(p.Ser389Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,736 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_182609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF677 | NM_182609.4 | c.1165A>G | p.Ser389Gly | missense_variant | 5/5 | ENST00000598513.6 | NP_872415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF677 | ENST00000598513.6 | c.1165A>G | p.Ser389Gly | missense_variant | 5/5 | 1 | NM_182609.4 | ENSP00000469391.1 | ||
ZNF677 | ENST00000333952.8 | c.1165A>G | p.Ser389Gly | missense_variant | 3/3 | 2 | ENSP00000334394.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151886Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251176Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135762
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461728Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727162
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152008Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74324
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2023 | The c.1165A>G (p.S389G) alteration is located in exon 5 (coding exon 3) of the ZNF677 gene. This alteration results from a A to G substitution at nucleotide position 1165, causing the serine (S) at amino acid position 389 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at